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Abstract
Background: There is a growing realization that alterations in host-pathogen
interactions (HPI) can generate disease phenotypes without pathogen invasion. The
gut represents a prime region where such HPI can arise and manifest. Under normal
conditions intestinal microbial communities maintain a stable, mutually beneficial
ecosystem. However, host stress can lead to changes in environmental conditions
that shift the nature of the host-microbe dialogue, resulting in escalation of virulence
expression, immune activation and ultimately systemic disease. Effective modulation
of these dynamics requires the ability to characterize the complexity of the HPI, and
dynamic computational modeling can aid in this task. Agent-based modeling is a
computational method that is suited to representing spatially diverse, dynamical
systems. We propose that dynamic knowledge representation of gut HPI with agent-
based modeling will aid in the investigation of the pathogenesis of gut-derived
sepsis.
Methodology/Principal Findings: An agent-based model (ABM) of virulence
regulation in Pseudomonas aeruginosa was developed by translating bacterial and
host cell sense-and-response mechanisms into behavioral rules for computational
agents and integrated into a virtual environment representing the host-microbe
interface in the gut. The resulting gut milieu ABM (GMABM) was used to: 1)
investigate a potential clinically relevant laboratory experimental condition not yet
developed - i.e. non-lethal transient segmental intestinal ischemia, 2) examine the
sufficiency of existing hypotheses to explain experimental data - i.e. lethality in a
model of major surgical insult and stress, and 3) produce behavior to potentially
guide future experimental design - i.e. suggested sample points for a potential
laboratory model of non-lethal transient intestinal ischemia. Furthermore, hypotheses
were generated to explain certain discrepancies between the behaviors of the
GMABM and biological experiments, and new investigatory avenues proposed to test
those hypotheses.
Conclusions/Significance: Agent-based modeling can account for the spatio-
temporal dynamics of an HPI, and, even when carried out with a relatively high
degree of abstraction, can be useful in the investigation of system-level
consequences of putative mechanisms operating at the individual agent level. We
suggest that an integrated and iterative heuristic relationship between computational
modeling and more traditional laboratory and clinical investigations, with a focus on
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Introduction
Dynamic host-microbe interactions in the gut: A new paradigm for microbe-associated
disease
The understanding of how microbes cause disease has evolved dramatically since the
introduction of Koch’s postulates and development of germ theory over a century ago.
Humans represent “below the skin” ecosystems, supporting vast and diverse intestinal
communities of microbial species that serve important roles in digestion, metabolism
and development. There is an increasing recognition of the importance and influence
of the gut microbiome in various disease states [1-3]. The host-microbe dialogue can
be transformed by changes in the constituent species or genetic background of coloniz-
ing flora, impairment of host defenses, or physiologic perturbations brought about by
host stress [4-6]. Recent evidence suggests that potentially pathogenic microbes
undergo virulent transformation during conditions of host stress [7-20]. Physiologic
changes associated with critical illness, coupled with consequent modern medical
therapies, can lead to escalation of virulence expression, immune activation and ulti-
mately systemic inflammatory dysregulation [7,21]. Given the scale and anatomic dif-
ferentiation of the interactive surface of the gut there will be considerable regional
heterogeneity in terms of bacterial species and local host factors. Therefore, it is rea-
sonable to characterize the gut ecosystem as a series of microenvironments where
regional differences in host conditions and bacterial populations can lead to divergent
ecological trajectories.
Host-pathogen interactions (HPI) consist of a series of mechanistic molecular-based
processes where microbial and host cells sense, respond to and influence their local
environments. While mechanisms for this phenomenon have been described for many
pathogens, we use the virulence activation in Pseudomonas aeruginosa in response to a
stressed gut milieu, and the effect of thusly activated P. aeruginosa on that milieu as
our model reference system. P. aeruginosa is a gram negative bacillus that is one of the
most clinically significant microbes in hospital settings, with a high degree of morbidity
and mortality associated with its presence [22]. P. aeruginosa virulence expression has
been identified as responding to local environmental cues, many of which are host tis-
sue factors released in response to physiologic stress, such as tissue ischemia [9],
immune activation [8], phosphate depletion [23-25] and endogenous opioid response
[26]. Each of these conditions corresponds to commonly observed clinical responses in
critically-ill, stressed patients, and in many clinical scenarios several, if not all, of these
host responses occur contemporaneously as a part of a global physiologic stress state.
These alterations in the baseline host physiological state may disturb the balance of
the baseline, non-pathologic HPI, and therefore may represent potential targets for
translational research directed at prevent i n gap a t h o g e n i cs h i f ti nt h eH P I .W ef o c u s
on representing the mechanisms and consequences of P. aeruginosa virulence activa-
tion in the gut of a stressed host as an example of how HPI associated with clinical
disease can be investigated through an iterative integration between traditional
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goals in this process:
1. The integration and dynamic representation of mechanistic knowledge of the com-
plex processes of P. aeruginosa virulence activation in the stressed gut. This is primar-
ily reflected in ABM development and initial implementation.
2. To use that dynamic representation as a means of knowledge visualization and
conceptual model verification: i.e. can the instantiation of the mechanistic hypothesis
in achieved in Goal 1 be made to behave in a plausible and recognizable fashion? This
is primarily accomplished in the initial model-testing phase of development (cross-
model validation).
3. To use the resulting GMABM as an in silico adjunct to examine experimental
conditions not currently explored using traditional experimental methods. This is pri-
marily manifest in the design and execution of simulation experiments.
4. Formulate new hypotheses arising from observed discrepancies between the ABM
and real-world observations and suggest how new experiments might be performed to
test these new hypotheses. This process takes place during the interpretation and ana-
lysis of the simulation experiments.
These goals represent a sequential process that mirrors the general scientific method;
we aim to demonstrate that the execution of that process within the context of devel-
oping and using a computational model can enhance the standard scientific workflow.
In silico dynamic knowledge representation of the HPI
The spatio-temporal biocomplexity of the host-microbe relationship has come into
focus as a key aspect of understanding the pathogenesis of clinical infections [27,28].
While molecular techniques for describing mechanistic details of microbial and host
physiology have yielded tremendous advances in characterizing mediators and path-
ways, reassembling that knowledge in a useful and practical context that effectively
represents the behavior of this complex biological system remains a formidable chal-
lenge. Techniques from systems biology can facilitate the integration, visualization and
manipulation of mechanistic knowledge and improve translational efforts [29-31], but
there is a clear need to be able to expand beyond the level of individual cells and char-
acterize the behavior of cellular populations [32,33].
Agent-based modeling represents one technique that offers specific advantages for
modeling spatially diverse, dynamic, multi-factorial systems, such as HPI in the gut
[31,34,35]. Agent-based models (ABMs) are composed of virtual environments popu-
lated with objects (agents) that execute behaviors based on programmed rules that
govern interactions with the local environment and other agents. The behavioral rules
for an agent can range in complexity from a series of Boolean conditional statements
to highly sophisticated mathematical models and decision algorithms, giving ABMs to
capacity to potentially incorporate multiple levels of mechanistic resolution and detail.
During execution of an ABM individual agent behaviors can vary based on differing
local conditions, and, in aggregate, produce population-level dynamics that represent
the dynamics of the system as a whole. Agent-based modeling has been used to dyna-
mically represent aspects of complex biological processes including inflammation
[29,36-41], cancer [42-45], infectious diseases [46-50] and wound healing [51,52].
There is also a growing recognition of the importance of spatial heterogeneity and
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[59,60]. By capturing the transition from individual agent behavior to the behavior of
populations of agents, ABMs are able to produce non-intuitive behavioral patterns that
may only manifest at the system-level. Examples of this type of system-level behavior
include phase transitions in physical systems [61], flocking/schooling behavior in birds
[62], fish [63] and other ecological systems [64] and quorum sensing in bacteria
[65,66].
Being able to capture this type of system-level phenomena is of critical importance in
the investigation of biological systems, since there are several levels of organization
between the level of mechanism targeted for putative control (often gene/molecule)
and the clinical relevance/implications of that intervention (whole organism). Each of
these levels of organization, extending from gene to molecule to cell to tissue to organ
to organism, represents a potential epistemological boundary where inferred conse-
quences at a higher level of organization cannot be assumed from identified mechan-
isms at a lower level. These boundaries challenge the fidelity of the modeling relation
between an experimental model (be it a biological lab system or a computational simu-
lation) and the biological referent, where the modeling relation is defined as the map-
ping of the generative processes and generated outputs between the model and its
referent [34,67]. Agent-based modeling used for dynamic biomedical knowledge repre-
sentation is a means of making the modeling relation more explicit. Executing an
ABM also evaluates the dynamic consequences of a particular mechanistic hypothesis
by extending the experimental context in which those mechanisms are executed, i.e. to
a higher level of biological organization. Dynamic knowledge representation aims to
bridge gaps between the context in which mechanisms are identified (i.e. pathway
information identified through in vitro experiments) and the multiple ascending scales/
contexts present during the translation of that knowledge into the clinical/organism
level (i.e. cell => tissue => organ => organism). We assert that one of the primary
modeling relation transitions in the study of biological systems occurs in the extrapola-
tion of single cell behavior into cellular population behavior at the tissue level. With
this in mind, we have chosen the cell-as-agent resolution level as a means of bridging
the intra-cellular molecular knowledge derived from in vitro experimental investiga-
tions to the population-level, space-incorporating, tissue and organ level context neces-
sary to represent clinically relevant behavioral dynamics.
Establishing Plausibility: The benefits of detailed, selectively qualitative dynamic
knowledge representation
Related to the issue of explicit representation of the modeling relation in the study of
biological systems is the question of what constitutes an appropriate level of model
representation and detail? The scope and scale of a modeling project is intimately tied
to and informed by its use. This is often termed establishing the experimental frame
[68,69]. Given the limits and incompleteness of biological knowledge, a pragmatic goal
of biomedical modeling and simulation is to aid in the discovery and evaluation of
potential plausible mechanisms. When operating within this discovery-oriented experi-
mental frame the first step in the evaluation of a hypothesis is determining its face
validity, and thus its plausibility. Face validity is defined as the ability of a particular
simulation to behave in a realistic, reasonable and believable manner, and represents
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the criteria for determining face validity are qualitative by nature: i.e. “Does this beha-
vior look right?” For example, such criteria might be that model behavior approximate
the behavior of the referent in terms of relative magnitude and timeline, and that
actual and predicted changes in model behavior occur in the same general direction as
seen in the referent. While admittedly a low bar in terms of assessment, the standard
of face validity is a useful and arguably necessary step while engaged in the “discovery”
phase of science; the behavior of putative hypotheses reasonably should at least pass
this test in order to be eligible for more rigorous testing [70]. Establishing face validity
can involve cross-model validation: the comparison of the output of the computational
model to a specific real world referent, which may itself be a reduced experimental
model of a more complex biological subj e c t .T h i sp r o c e s si n c l u d e st r y i n gt o“coerce”
the computational model (generally through parameter manipulation) to reproduce
data from the referent; the inability to do so within the bounds of plausible manipula-
tion (for example, if cells are required to move at rates not compatible with the imple-
mentation of their other functions in order to produce a desired model output)
suggests that the underlying hypothesis structure is incorrect. Conversely, if the com-
putational model is able to generate output acceptably matched to data from its refer-
ent, it is considered to be plausible and is subjected to further use and testing.
ABM of HPI in the gut milieu
The use of agent-based modeling for this type of knowledge representation has been
previously described in the biomedical arena [36,71-73], and represents our strategy for
the development of an ABM concerning P. aeruginosa virulence activation in the
stressed gut. We aim to represent virulence-associated signal transduction and gene
regulatory processes identified in P. aeruginosa with a relatively high degree of compo-
nent detail, but abstracted in terms of the actual biochemical kinetics. Rate constants
for classes of biochemical events are assumed to operate within qualitative orders of
magnitude, and therefore, highly-abstracted representation of biochemical kinetics, as
either Boolean, logic-based or algebraic statements, can be of sufficient descriptiveness
to produce ABM behavior that pattern-matches those seen in the experimental data
[73-76]. We note that when using this approach the relationship between the compo-
nents (and their respective mechanisms) is of critical importance [34,67]. Our emphasis
on “selectively qualitative” can be considered a means of relational representation and
grounding, as we focus on representing the relationships between the modeled compo-
nents to produce recognizable and plausible behaviors.
The current ABM represents an initial, relatively abstract example of dynamic knowl-
edge representation of the gut HPI, and in the future the modular nature of ABM will
allow graduated addition of agents and variables (such as inflammatory cells, goblet
cells, sub-epithelial tissue architecture and vascular system), as well as more complex
rules for individual agents (such as mathematical models of signal transduction or gen-
ome-scale metabolic models), to produce higher resolution models of the gut HPI.
However, we suggest that dynamic knowledge representation using even relatively
abstract ABMs can play a useful role in the current scientific process.
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Overview
We developed a series of ABMs of virulence regulation in P. aeruginosa using Netlogo,
an agent-based modeling software toolkit [77]. The rules for agents representing P.
aeruginosa were developed using a series of modular submodels, each submodel focus-
ing on a particular set of in vitro experiments examining one particular activation
pathway by host-derived stress signals: immune-activation, mediated through the mole-
cule interferon-g (IFN-g) [8], ischemia, manifest as reduction in blood flow and oxygen
availability, and reflected in the production of adenosine [9], endogenous opioids, man-
ifest as dynorphin [26], and phosphate depletion, seen concurrent with major surgical
stress [23-25]. The rules for agents representing gut epithelial cells were abstracted
from previously published ABMs involving tight junction metabolism and inflamma-
tory response in gut epithelial cells [36]. Submodels were cross-model validated to data
from their corresponding experimental referents, and then integrated into an aggre-
gated ABM that included additional organ-level variables (mucus, commensal flora,
nutrients and soluble host factors) to simulate an in vivo gut environment of a stressed
host. We term this integrated ABM the gut milieu agent based model (GMABM). A
text file of the code for the GMABM can be seen in Additional File 1 while the
Netlogo model can be downloaded from http://bionetgen.org/SCAI-wiki/index.php/
Main_Page.
The process of constructing the GMABM, which we treat as an analog to in vivo
experimental models, is similar to the knowledge transfer associated with “wet lab”
progression from in vitro models to more complex animal models, with the added ben-
efit of having explicit transparency in terms of represented mechanisms. Conditions of
systemic host stress were then simulated to observe interactions between Pseudomonas
agents and the gut barrier manifest as alterations in population characteristics, spatial
distribution of effects, and aggregate system-level variables. The results of these simula-
tions were compared with animal models (in vivo referents) to evaluate the plausibility
of interactions and to identify knowledge gaps when outcomes were divergent. It
should be noted that the agent-rule structures were not changed in the process of sub-
model integration other than at necessary points of submodel intersection (i.e. shared
components).
In an effort the move towards standardization of ABM development and analysis,
Grimm, et al. have described the Overview, Design Concepts, Details (ODD) protocol
to describe the construction and use of an ABM [78]. This protocol was initially devel-
oped with ecological modeling in mind, though its use has been expanded to other
applications of agent-based modeling [48,78]. We have used a modified version of the
ODD protocol as the organizational structure of this Methods section.
Design Concepts: Utilizing a bacteriocentric perspective
Existing published ABMs of HPIs during infection have a distinctly immunocentric
focus with simplification of the spatial and temporal aspects of phenotypic expression
of pathogens [57,79-81]. Alternatively, the bacteriocentric organization of the GMABM
emphasized the mechanisms of microbe virulence activation and represents host func-
tions primarily as modifiers of the mucus milieu by secretion of signaling molecules
and depletion of resources. While in biological referents the host response to
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components, representation of host defenses was limited in the GMABM to basic bar-
rier functions associated with gut epithelial cells and an abstracted immune response
in order to focus the GMABM on virulence regulation in P. aeruginosa. We recognize
the potential limitations of this approach, but given the focus of prior investigations
we believe that we can provide a novel scientific contribution through our bacterio-
centric focus.
Entities, State Variables and Scales
The agent level of the ABM is the cellular level, representing individual P. aeruginosa
bacteria ("Pseudomonas agents”) and gut epithelial cells ("GEC agents”). The spatial
configuration of the ABM is a 2-dimensional square grid with the 3
rd dimension repre-
sented as 4 overlying data layers: the intestinal lumen, the gut mucus layer, the gut
epithelial layer and the systemic circulation (see Figure 1 and 2). The grid is toroidal,
as to avoid edge effects. The GMABM is abstracted with one grid space ("patch”)
approximating one GEC agent. GEC agents reside in the gut epithelial layer. At base-
line, Pseudomonas agents reside in the gut mucus layer; if the mucus is depleted then
they can directly interact with the GEC agents. There is an arbitrary limit of 20
Figure 1 Architecture and topology of the ABM. The ABM simulates the 3-dimensional relationships of
the gut-luminal interface by utilizing “stacked” data layers, each one representing a two-dimensional aspect
of the gut-microbial interaction environment. It should be noted that the “stacking” occurs only in a virtual
sense. This approach is akin to that used in geographical information systems (GIS) [102]. Representative
layers depicted include luminal phosphate concentration (green patches), endogenous gut flora population
(brown patches), mucous barrier (yellow patches), and epithelial cell tight junctions (violet patches). Agents
interact within and between data layers as depicted by Pseudomonas agents (red pentagons) in the
mucous and epithelial layers and epithelial cell agents (blue squares) in the epithelial cell layer and
interface with the systemic circulation. Simulation world data is passed from one data-layer to the next
based on encoded rules in the ABM. Run-time visualization of model layers or variables can be modified at
the user interface with application of filters for specific variables to be displayed in the 2-dimensional
graphical interface (see Figure 2).
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agents that can reside on the discretized space represented by a single patch and are
treated as a well-mixed population within the spatial resolution of the patch. Patch
variables include extra-cellular molecules and populations of commensal bacteria;
extracellular molecules are specified with tags associating them with their model layer
location: lumen, mucus, epithelial and circulatory. There are three patch variables not
generated by cellular agents (Pseudomonas or epithelial): phosphate, mucus and com-
mensal bacteria. The first two have a random value (normal distribution) within a
range: phosphate between 0 and 99 where the upper value can be varied as an experi-
mental condition, and mucus between 90 and 100 not varying unless degraded by acti-
vated Pseudomonas agents. The variability of the values is meant to reflect the
heterogeneous nature of the gut environment. Commensal bacteria are modeled as an
aggregate population variable within the gut mucus layer rather than individual agents
due to their relatively passive role in the GMABM (see below in the Submodel sec-
tion). The state variables for the Pseudomonas agents and the GECs represent molecu-
lar level components internal to the cells: receptors, signaling factors, gene
transcription factors, genes and structural molecules. The molecular pathways are
represented qualitatively, thus the corresponding variables are unit-less, but with a
considerable degree of component detail, consistent with our previously described
method of detailed, selectively qualitative modeling [36,71-73]. This approach consists
of relatively detailed component representation (i.e. including specific enzymes, mole-
cular species and genes) with qualitative representation of biochemical kinetics using a
fuzzy Boolean logic-based rule construction. Molecular interaction rules are expressed
as conditional statements of the form:
if Ligand A is present (or above some threshold), then bind to and activate Receptor
B
if Receptor B is activated, then increase Signal Transduction Enzyme C by 1
And so on...
For a comprehensive list of entities and state variables included in the GMABM see
Figure 2 Screenshots of different backgrounds representing data layers. Representative patch
backgrounds depicting endogenous gut flora population (brown patches), mucous barrier (yellow patches),
epithelial cell tight junctions (violet patches) and epithelial cells (blue GECs on white background). Shading
of background color reflects quantitative changes in specific variables (e.g. mucous, endogenous flora, tight
junctions). Pseudomonas agents (red pentagons) move to survey microenvironments while epithelial cells
(blue squares) modify local conditions in response to host stress. This feature of the ABM aids in initial
code development to visually identify encoded behaviors, provides visual reinforcement of expected model
behavior and facilitates the use of visual intuition to identify patterns and behaviors that might not be
evident in purely tabular data output.
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2. Figures 3, 4, 5, 6 and 7 are schematic directed graphs of the various virulence path-
ways implemented in the GMABM Pseudomonas agents. In the ABM each node-edge-
node relationship displayed in the schematic is represented by fuzzy Boolean rules in
the general format noted above. The code of the GMABM can be seen in Additional
File 1.
Collectives and Observations
The set of observables for the GMABM is informed and determined by the type of
data generate by the biological referents, be they in vitro or in vivo models. The scalar
metric output of the GMABM for cross-model validation and simulation experiments
are population metrics that represent aggregated output from the individual agents in
the GMABM. These scalar metrics correspond to global levels of mediators (measured
from the GMABM as a whole) and cell populations, either in total for an agent class
or a specific subpopulation. This data can be seen in the outputs of the cross-model
validations and simulation experiments. In addition to these scalar metrics, visual pat-
terns of the simulation world observable through Netlogo’s graphical user interface.
While not quantitative information, the visualized behavior of the GMABM provides a
qualitative means of evaluating the plausibility of the dynamics generated.
Process Overview and Scheduling
The GBABM uses iterated, discrete time steps, each step corresponding to 5 minutes
of real time. As per Netlogo convention, each run step is divided into several sub steps.
Sensing: Role of Quorum Sensing and Implementation in the in vivo GMABM
Expression of virulence genes in P. aeruginosa is predominantly controlled by quorum-
sensing (QS) regulatory mechanism, a highly conserved “network of networks” regulat-
ing hundreds of genes in response to inter-cellular signaling molecules at high popula-
tion densities [82-84]. While a comprehensive representation of these feedback
networks is beyond the scope of GMABM, select components relevant to host-derived
cues were included. Although emerging evidence suggests that QS may be less depen-
dent on population density in certain contexts [85], for the purposes of the GMABM,
recognition of sufficient local population density by Pseudomonas agents was a pre-
condition for virulence activation and expression. The “sufficient” threshold of local
Pseudomonas agent population density to trigger the quorum signal is a user-defined
initial condition (qualitative scale), while the strength of the virulence expression is
augmented by stress-induced host factors. Virulence expression requires both an
increase in the simulated bacterial population level beyond set threshold (an initial
parameter in the GMABM) and the presence of simulated host stress signals. While in
the real world system there is very likely a dynamic interplay between the quorum sig-
nal threshold and the mediator milieu for the bacteria, given the current resolution of
the GMABM we have chosen to focus on the more direct effects of host stress signal-
ing via adenosine, IFN-g, dynorphin and phosphate. This is reflected in the Experi-
ments section where the quorum signal threshold was set at a relatively low value,
thereby placing focus on the effects of the above noted mediators.
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Agents and
Variables
Rules
Epithelial cell agents One agent per patch, fixed (Blue Squares)
i-Interferon-g Intracellular production of interferon-ϒ released during inflammation
i-Dynorphin* Intracellular production of dynorphin, released during ischemia/reperfusion, dynorphin
expression enhanced by factor of 3 when Pseudomonas agent present
i-Adenosine Intracellular production of adenosine, released during ischemia
HIF-a Intracellular signal for adenosine production during ischemia
TJ-level Intracellular production of tight junction proteins, turnover 90 minutes
Pseudomonas
agents
Random distribution, heading, and movement (Red Pentagons)
i-Dynorphin* Uptake of extracellular dynorphin and activator of mvfr
oprF* Membrane-bound receptor, activation proportional to [interferon-ϒ]
RhlRI* Conserved quorum-sensing molecule, regulated by oprF
Luxbox* Response element upstream of lecA
i-adenosine Uptake of extracellular adenosine
Adenosine-
deaminase*
Converts adenosine to inosine
Inosine* Activates lecA
PstS* Membrane-associated protein, activation proportional to [Pi]
PhoR* Intermediate phosphate signaling molecule
PhoB* Intermediate phosphate signaling molecule, binds to phobox
pho box* Response element upstream of mvfr
lecA* Gene for PA-I lectin expression, activated by inosine, PQS, luxbox
i-PA-I-lectin Intracellular production of PA-I lectin, causes binding to epithelial cells
Mvfr* Multiple virulence factor, upstream promoter for quorum sensing virulence
TNA* Downstream to mvfr (See mvfr box in Table 2).
pqsABCDE* Downstream to TNA
i-HQNO* Intracellular QS intermediate molecule, toxic to Lactobacillus spp.
i-PQS* Intracellular QS intermediate molecule, activates lecA, form epithelial toxin
Grow-colony Proxy for growth signal when resources (mucous layer) > endogenous flora
Quorum-sense Recognizes quorum based on concentration of quorum-signal
Patch Variables
Mucous Initial value between 90 and 100 per patch (normal distribution), remains constant and
determined carrying-capacity for gut environment (proxy for food, space, shear
clearance)
Phosphate Initial concentration random value in normal distribution between 0 and 99 (arbitrary
units), where the upper value is controlled through the user interface as an
experimental condition
Endogenous
flora
Initial population at maximum carrying capacity, growth impaired by HQNO
HQNO* Produced by Pseduomonas agents, a toxin that impairs growth of endogenous flora,
decreases competition allows for population growth
PA-I lectin* Produced by Pseudomonas agents, a toxin that causes epithelial barrier dysfunction
Quorum-signal Produced by Pseudomonas agents, an intercellular communication molecule by which
Pseudomonas agents sense Pseudomonas density
This table presents a list of the agent classes representing cellular, bacterial and environmental types, variables of those
types corresponding to identified mediators and compounds, and the rule-sets for behavior involving those compounds
as instantiated in the ABM. It should be noted that the list of rules reflects the programming code semantics for the
biological mechanisms of the simulated compounds. For a more detailed biological description of selected compounds
(noted by an asterisk “*”) readers are directed to Table 2.
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The GMABM is a spatially explicit model, where interactions between agents and their
environment are defined by the parcel of discrete space occupied by the agent ("patch”
in Netlogo parlance) as well as the Moore neighborhood of that patch, where the
Moore neighborhood on a 2-D square grid consists of the 8 squares immediately adja-
cent to and surrounding the central square. Biological cell-agent to biological cell-
agent interactions are generally mediated through the passage of environmental vari-
ables produced and sensed by the various agent types; specific cell-to-cell contact
interactions (other than adhesion reflected as cessation of Pseudomonas agent move-
ment) are not included in the current development of the GMABM.
Table 2 Biological Description of Selected Simulation Rules and Variables
Compound Biological Description
Dynorphin Class of opioid peptides, activator of MvfR
OprF Outer membrane protein, binds INF-g to enhance virulence
RhlRI Quorum sensing subsystem composed of RhlI, the C4-HSL (N-
butyrylhomoserine lactone) autoinducer synthase and RhlR transcriptional
regulator, activates as a consequence of binding INF-g to OprF
lux box DNA sequence with dyad symmetry located in the promoter regions of many
quorum-sensing-controlled genes including lecA. Functions as binding site for
quorum sensing transcriptional regulators RhlR and LasR.
Adenosine-deaminase Converts adenosine to inosine
Inosine Activates lecA expression
PstS Phosphate-binding protein, induced by phosphate limitation
PhoR Two-component (PhoR/PhoB) sensor kinase, activated during phosphate
limitation as a consequence of PstS expression.
PhoB Two-component (PhoR/PhoB) transcriptional regulator for phosphate regulon
genes. Phosphorylation of PhoB by PhoR enhances its binding activity to pho
box.
pho box DNA conserved sequence located in promoter region of phosphate regulon
genes, including mvfR.
lecA Gene encoding PA-I lectin, the expression is regulated by quorum sensing.
Exposure of P. aeruginosa to epithelial cell agents adenosine, opioid, and INF-g
induces the expression of lecA.
MvfR P. aeruginosa LysR-type transcriptional regulator, modulates the expression of
multiple quorum sensing (QS)-regulated virulence factors, regulates the
biosynthesis of 4-hydroxy-2-alkylquinolines (HAQs) including HQNO and PQS.
mvfR box (corresponds to
TNA in Table 1)
DNA consensus palindromic sequence T-[N]11-A with a dyad symmetry located
in promoter region of MvfR-regulated genes including pqsABCDE.
pqsABCDE Operon regulated by MvfR, encodes proteins required for the biosynthesis of
HQNO and HHQ, a precursor of PQS. HHQ and PQS potentiate MvfR binding to
mvfR box upstream of pqsABCDE forming feedback loop regulation.
HQNO 4-hydroxy-2-heptylquinoline-N-oxide, the P. aeruginosa exoproduct regulated
by QS, suppresses the growth of many gram-positive bacteria including
Lactobacillus spp., mediates protection of Staphylococcus aureus against
aminoglycosides antibiotics.
PQS 2-heptyl-3-hydroxy-4(1 H)-quinolone, the P. aeruginosa exoproduct regulated
by QS, plays multifunctional role in quorum sensing including intra-cellular and
inter-cellular signaling. Shapes the population structure of Pseudomonas and
response to and survival in hostile environmental conditions. Induces apoptosis
in mammalian cells.
PA-I lectin Pseudomonas toxin causes potent epithelial barrier dysfunction
This table presents a more detailed biological description of selected compounds within the ABM (items with an asterisk
“*” from Table 1) that are specifically related to gut host-microbial crosstalk and virulence activation. Readers are
encouraged to examine Tables 1 and 2 to see how biological descriptions are converted to ABM rules.
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The existence of stochasticity in intracellular signaling and gene regulation are well
accepted [86] and this property is incorporated into the rules for signal transduction,
receptor dynamics and gene regulation/expression through the addition of random
number modifiers to the likelihood of particular events. The Netlogo software toolkit
utilizes the Mersenne Twister as its pseudo-random number generator for its “random”
primitives.
Initialization
There is no dynamic initialization run-period in the GMABM; this means that simula-
tion t = 0 is intended to represent an arbitrary time point in a system that is already at
steady state. Baseline simulation conditions represent the reference system in its non-
perturbed state, with “normal” levels of bacterial nutrients (including phosphate), fully
intact mucus layer, baseline levels of commensal bacteria, GECs with fully intact tight
junctions and no active inflammatory mediators. Pseudomonas agents are present, but
in the absence of virulence activating cues (see Submodel section below) they do not
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Figure 3 Schematic of P. aeruginosa virulence activation pathway due to adenosine, a host product
of ischemia/reperfusion. Intestinal ischemia and reperfusion leads to the production of HIF-1a, which
induces the release of adenosine into the intestinal lumen. Adenosine is transported into the bacterial
where it is converted to inosine by adenosine deaminase. Inosine induces the expression of the coding
region lecA, which is transcribed and translated into the protein PA-I lectin, which is secreted into the
intestinal lumen and causes epithelial barrier dysfunction. All the above molecular components are
represented by state variables in the GMABM, and the directional arrows indicate the presence of state
transition rules.
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Page 12 of 34have their corresponding virulence pathways active. The baseline, non-perturbed state
of the GBABM was demonstrated to be stable through as series of non-perturbed
simulation runs to 1000 time steps.
Submodels
This section will describe in detail the underlying biology and the implementation of
that biology in the two mobile agent classes: Pseudomonas agents and GEC agents.
Pseudomonas agent functions are subdivided into response pathways to specific condi-
tions associated with host stress: ischemia, phosphate depletion, inflammation and
opioid presence. The GEC agent functions can be classed into two groups: the first
represents the representation of gut barrier function, the primary host function affected
by microbial virulence, the second group consists of assignment to GEC agents three
of the stress conditions discussed above: ischemia, inflammation and opioid produc-
tion. In addition, while not a specific agent class, a subsection describing the handling
of commensal bacteria as a population-based patch variable is described.
Entity #1: Pseudomonas Agents:
Each virulence activation component was developed with a submodel ABM to allow
cross-model validation with their respective experimental referents. Subsequently, the
rule sets of these modular submodels were integrated into a single model (the
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Figure 4 Schematic of P. aeruginosa virulence activation pathways due to bacterial sensing of low
phosphate. Low phosphate in the mucous layer of the intestine is sensed by P. aeruginosa through PstS
protein. This activation of PstS results in changes in the Pst-PhoU-PhoR complex, leading to histidine kinase
PhoR phosphorylation and activation of the transcriptional regulator PhoB that then binds to the pho box
gene sequence that controls hundreds of genes including those encoding main regulators of quorum
sensing, such as MvfR. MvfR is a transcriptional regulator that acts upstream of the operon pqsABCDE,
which codes for, among other things, the enzymes that lead to the production of PQS, a quorum sensing
compound, and the bactericidal compound HQNO. PQS serves three additional functions: 1) activates lecA,
which leads to the production of PAI-lectin, 2) is secreted to bind to free iron (Fe), and 3) feeds back to
enhance the binding of MvfR to the promoter sequence upstream of pqsABCDE. All the above molecular
components are represented by state variables in the GMABM, and the directional arrows indicate the
presence of state transition rules.
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Page 13 of 34GMABM) intended to be a computational analog to animal models and other more
physiologic experimental platforms. Simulated experiments were then performed on
the integrated GMABM. Figures 3, 4, 5 and 6 demonstrate schematic representations
for each of the four individual virulence pathways represented in the Pseudomonas
agent. The aggregated set of pathways present in the GMABM is seen in Figure 7. The
following sections will describe each submodel and its associated biology.
￿ Ischemia: Adenosine-mediated virulence activation
Intestinal ischemia is a contributing factor in the pathogenesis of gut-derived sepsis
[9,26]. Intestinal ischemia was simulated by initiating GEC agent expression of its state
variable HIF-1a, which initiates production and release of adenosine as an environ-
mental variable. Environmental adenosine present on patches occupied by Pseudomo-
nas agents is converted by adenosine deaminase within the Pseudomonas agents to the
internal state variable inosine and initiates the time-scaled expression of cytosolic PA-I
lectin (i-PAI-lectin to denote the location of the variable). The time course for peak
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Figure 5 Schematic of P. aeruginosa virulence activation pathways due to interferon-g, a product of
host inflammation. Host cells subject to inflammation secrete the cytokine interferon-g (IFN-g). IFN-g binds
to outer membrane porin OprF on P. aeruginosa. Bound OprF activates RhlI, a N-(butanoyl)-L-homoserine
lactone synthetase in the quorum sensing system, which in turn is required for PA-I lectin production. All
the above molecular components are represented by state variables in the GMABM, and the directional
arrows indicate the presence of state transition rules.
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Page 14 of 34expression of PA-I lectin in in vitro models was in the range of 5-7 hours, and the
Pseudomonas agent signal transduction pathway of inosine interaction with the lecA
complex was tuned to peak production of i-PAI-lectin at 5 hours. Because expression
of PA-I lectin is associated with adhesion to the epithelial cell layer, Pseudomonas
agents with positive i-PAI-lectin became fixed to their current patch. Translocation of
PA-I lectin to the cell wall was represented as conversion of the agent variable i-PAI-
lectin to the patch variable PA-I lectin. The expression and integrity of epithelial tight
junctions (occludin) was inversely proportional to patch PA-I lectin concentration,
resulting in discrete regions of increased epithelial cell layer permeability around acti-
vated microbes. A schematic for this virulence pathway is seen in Figure 3.
￿ Phosphate depletion, P. aeruginosa phosphate sensing and virulence activation
In critical illness and post-surgical stress serum and extra-cellular hypophosphatemia
results from phosphatonin-mediated urinary wasting [87,88] and sequestration by vitals
o r g a n s( h e a r t ,b r a i n ,e t c . ) .I nt h eA B M ,t h e initial phosphate concentration for each
patch was randomly set at given a normal distribution between 0-99 (arbitrary units),
but the upper range modifiable through the user interface. The variable state repre-
senting the conformational structure of the internal agent variable PstS phosphate-
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Figure 6 Schematic of P. aeruginosa virulence activation pathways due to bacterial sensing of
endogenous opioids, a product of host stress. Endogenous opioids are release by host tissues during
systemic stress. Dynorphin, a synthetic agonist used to study opioid receptors, activates the transcriptional
regulator MvfR, and leads to the expression of its regulated operon pqsABCDE and subsequent
downstream products production of HQNO, and PQS, as noted above in the low phosphate signaling
pathways (Figure 4). All the above molecular components are represented by state variables in the
GMABM, and the directional arrows indicate the presence of state transition rules.
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Page 15 of 34sensing molecule was determined by the phosphate concentration of the current patch.
Signal transduction pathways for low phosphate sensing initiated by activation of PstS,
including conformational changes in Pst-PhoU-PhoR complex and eventual phosphory-
lation of transcriptional regulator PhoB were represented as internal agent variables
with shared QS components (i.e. MvfR, PQS). A schematic for this pathway can be
seen in Figure 4.
￿ Inflammation: interferon-g (IFN-g) activation of multiple virulence pathways
Early recognition of host immune activation could enhance the efficacy and coordi-
nation of microbial defense and virulence strategies against host immunity. In P. aeru-
ginosa, cytokine-rich media from activated cultured T-cells induces PA-I lectin
expression at transcriptional and translational levels [8]. IFN-g produced by the host is
bound to outer membrane porin OprF on Pseudomonas agents. This activates the
expression of PA-I lectin. The RhlI, a N-(butanoyl)-L-homoserine lactone synthetase in
QS system is activated during exposure to IFN-g and required for PA-I lectin expres-
sion; this suggests a link between OprF and RhII. OprF, RhlI, and PA-I lectin are Pseu-
domonas agent state variables implemented in a time-scaled pathway to yield peak PA-
I lectin expression 6-7 hours following interferon binding, replicating the time course
of in vitro studies. The current GMABM does not include inflammatory/immune cells;
therefore activation of the inflammatory response and subsequent production of IFN-g
is incorporated as a function of GEC agents controlled at the user interface as a
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Figure 7 Schematic of aggregated P. aeruginosa virulence activation pathways associated with host
systemic surgical stress. A summary of the four virulence pathways depicted in Figures 3, 4, 5 and 6 is
presented in aggregated form. Note the points of convergence and intersections among the different
pathways, particularly in terms of downstream effects, suggesting highly conserved and advantageous
functions for the virulence outputs of P. aeruginosa. Also note the putative link between low phosphate
sensing and opioid sensing reflected by the association between pho box and MvfR (seen in the box
outlined in Red). MvfR is clearly an important control point in the phenotypic switching between non-
virulent and virulent states, and represents a target for future investigation.
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Page 16 of 34simulation experimental condition. A schematic of this virulence pathway is seen in
Figure 5.
￿ Endogenous opioids during host stress and virulence activation
Endogenous opioids are diffusely released during host stress and represent a poten-
tial early danger signal for microbes in richly innervated tissues such as the intestinal
tract [89-92] and can induce robust, multi-faceted virulence expression in P. aerugi-
nosa through activation of key transcriptional regulator MvfR, expression of its regu-
lated operon pqsABCDE and production of downstream signaling molecules HHQ,
HQNO, and PQS [26]. HQNO is a potent toxin against gram-positive bacteria includ-
ing Lactobacillus species, a common representative of endogenous human flora, con-
ferring a competitive advantage for scarce resources in the human gut. PQS, when
complexed with scavenged iron and emulsified with secreted rhamnolipids, forms a
potent toxic complex that induces apoptosis in intestinal epithelial cell. MvfR, NNQ,
NQNO and PQS were represented as Pseudomonas agent state variables in time-
scaled, semi-quantitative signal transduction pathways resulting in the three key viru-
lence products. The schematic for dynorphin sensing can be seen in Figure 6. Of parti-
cular interest is a putative link between the pho box complex and MvfR, which would
tie together the pathways for dynorphin and phosphate sensing. This putative interac-
tion is demonstrated in red in the overall schematic for all four virulence pathways
seen in Figure 7.
Movement
Non-adhered Pseudomonas agents move one grid-space per simulation run step in a
random fashion; there is no chemotaxis modeled. However, the presence of i-PA-I lec-
tin, produced through pathways for ischemia and inflammation, leads to adhesion of
Pseudomonas agents to underlying GEC agents and cessation of movement.
Entity #2: Gut epithelial cells
While the epithelial cell layer primarily governs the reactive surface of the host in the
gut milieu, there are notable contributions from various epithelial subtypes (such as
goblet cell, which produce mucus) and a host of inflammatory cell subtypes. Given our
focus on P. aeruginosa virulence activation, we have abstracted and assigned these host
functions to the GEC agents as an aggregated proxy for the host component of the gut
milieu. The role of gut epithelial cell population behavior as a proxy of host health is
represented in their permeability barrier function, reflected as tight junction integrity
by the GEC agents.
￿ Epithelial permeability and tight junction metabolism
The tight junctions are maintained at a steady state though metabolic and localiza-
tion processes, and these pathways are known to be subject to disruption by inflamma-
tory signals [36,71] and, specifically, the production of PA-I lectin by P. aeruginosa
[93]. Tight junction failure and subsequent increase in epithelial barrier permeability is
a well-recognized sign of gut inflammation and a precondition associated with gut-
derived sepsis [36]. Epithelial barrier function can also be compromised by apopotosis,
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produced toxin PQS [6]. GEC agents represent tight junction protein metabolism with
dynamic, time scaled turnover of a representative tight junction protein, occludin as a
GEC state variable, to its half-life of ~90 minutes (= 18 simulation steps) [94]. Without
perturbation to the system, appropriately localized occludin remains at a steady state to
maintain tight junction levels and effective epithelial barrier function. The presence of
patch PA-I lectin produced by activated Pseudomonas agents interrupts occludin
synthesis and results in GEC agent tight junction failure, manifesting as regional loss
of barrier function and increases in permeability.
Simulation control through the epithelial cell agents
User controls on the ABM allowed the possibility of independent simulation of specific
aspects of host stress as manifest by the epithelial cell agents (ischemia, inflammation,
endogenous opioids and phosphate depletion).
￿ Intestinal Ischemia
When “Ischemia” is activated via the User Interface the GEC agents produce HIF-1a,
which is added as the initiating factor to the production of adenosine by the GEC
agents. The adenosine has an intracellular component, which is a state variable for the
GEC agents and represents production, and a secreted version, which is released by
the GEC agents and diffuses into the environment. The secreted form of adenosine is
the environmental patch variable that activates the ischemia signaling rules of the
Pseudomonas agents (see above). Furthermore, during the time when “Ischemia” is
active the GEC agents decrement their “life” state variable such that they will die if the
“Ischemia” persists for 24 hours of simulated time.
￿ Intestinal Inflammation
As noted above, the GMABM does not include inflammatory cells and the inflamma-
tory response of the gut as an organ is abstracted by the production of IFN-g by GEC
agents. When “Inflammation” is activated (via the User Interface) the GEC agents pro-
duce IFN-g as a diffused environmental variable that activates the inflammation signal-
ing rules of the Pseudomonas agents.
￿ Endogenous opioid production
When “Stress” or “Ischemia” is activated (via the User Interface) the GEC agents
release dynorphin, a representative -opioid, as a diffused environmental variable that
activates the opioid signaling rules of the Pseudomonas agents.
Modeling commensal flora as a source of competition for resources
At baseline, both Pseudomonas agents and commensal flora existed within the mucous
layer. Commensal flora are represented as patch variables representing aggregate popu-
lations of common intestinal bacteria (such as Lactobacillus species, Bacteroides spe-
cies). While we recognize that a high degree of diversity exists among commensal gut
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lacking the genetic background or molecular machinery to express significant virulence
towards the host. Because populations of commensal flora are typically several magni-
tudes greater than those of colonizing microbes, commensal flora was abstractly repre-
sented as an environmental spatial variable discretized on the model grid space (as
opposed to agents) in order to produce a more realistic scale given computational con-
straints. Populations of both commensal bacteria and Pseudomonas agents were lim-
ited by a finite carrying capacity determined by the volume (thickness) of mucous layer
at a specific point in the virtual environment [95]. The growth dynamics of the com-
mensal bacteria are highly abstracted to linear growth with an upper limit based on
the mucous-dependent carrying capacity, and their competition limiting the number of
non-virulent Pseudomonas agents is manifest by their subtraction of available resource
on a particular patch. The mucous layer was modeled as an environmental data layer
with properties distinct from the intestinal lumen, particularly in terms of representing
available space and nutrients for the simulated bacterial populations. As the carrying
capacity of the simulated mucous layer is limited with respect to space and nutrients,
Pseudomonas agents have the potential to expand their niche within that environment
by eliminating competing commensal flora (i.e. targeted killing of Lactobacillus). At
the current time, the dynamics of mucous production, sloughing and turnover were
not incorporated into the GMABM.
Cross-model validation of submodel ABMs to biological experimental referents
The ABMs for each of the four central host-derived signals for virulence expression in
P. aeruginosa were cross-model validated to their respective experimental referents
prior to their integration into the GMABM, which was then used to perform simulated
experiments to examine the system level consequences of stress on the gut ecosystem.
The summary results of these simulations can be seen in Figures 8, 9, 10, 11, 12 and
13. Representative data figures from the referent publications can be seen in Additional
Files 2, 3, 4, 5 and 6.
￿ Effects of adenosine resulting from ischemia/reperfusion
Ischemic conditions simulating occlusion of mesenteric vessels were established by
adjusting control settings on the user interface that initiated production of HIF-a and
release of adenosine by GEC agents to match the published data in Patel et al [9]
(representative figure seen in Additional File 2). The relatively short half-life, rapid dif-
fusion and uptake by Pseudomonas agents were reflected in the diffusion and degrada-
tion parameters in the GMABM. Simulated transient ischemia/reperfusion (30
minutes) yielded peak PA-I lectin expression 7 hours after activation with time-cali-
brated events to account for absorption and enzymatic conversion to inosine, a potent
activator of lecA promoter for PA-I lectin (Figure 8).
￿ Effects of hypophosphatemia
P. aeruginosa is sensitive to ambient phosphate concentrations and responds to
phosphate depletion by expressing a robust virulent phenotype. The model output
Seal et al. Theoretical Biology and Medical Modelling 2011, 8:33
http://www.tbiomed.com/content/8/1/33
Page 19 of 34behavior of these pathways as implemented in Pseudomonas agents was fitted to the
data published in Long et al [23]. Note that the representative figure in Additional File
3 is a lethality curve that represents the time course of the activity of PstS and PA-I
lectin discussed within that paper. The phosphate depletion induces the expression of
the Pseudomonas agent phosphate sensor PstS; interacting with the same QS circuitry
as other host-derived cues, low phosphate concentration leads to peak MvfR activation
at 7 hours and PA-I lectin expression at 10 hours with plateaus present until 24 hours
(Figure 9).
￿ Effects of interferon-g due to immune activation
P. aeruginosa recognizes host immune activation through binding of interferon-ϒ to
membrane-bound OprF receptor and interaction with the QS circuitry. The model
output behavior of these pathways as implemented in Pseudomonas agents was fitted
PA-I lectin
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Figure 8 Cross-model validation of virulence expression in Pseudomonas agents to experimental
model of transient ischemia. This figure demonstrates adenosine-induced Pseudomonas agent
expression of lecA and subsequent production of PA-I lectin. PA-O lectin would then lead to reduced
expression of tight junction proteins in GEC agents (see Additional File 2 for sample experimental referent
data).
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Figure 9 Cross-model validation of virulence expression in Pseudomonas agents to experimental
model of low phosphate. These simulations of low phosphate conditions show the results of
Pseudomonas agent virulence activation in response to low phosphate sensing, reflected in the production
of PstS, MvfR, lecA and PA-I lectin (see Additional File 3 for sample experimental referent data).
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Page 20 of 34to the data published in Wu et al [8] (see representative figure in Additional File 4).
With similar signal transduction architecture to other sense and response mechanisms,
Pseudomonas agent peak PA-I lectin expression follows IFN-g concentrations and
peaks at 7 hours (Figure 10).
￿ Effects of endogenous opioids
The model output behavior of the effects of dynorphin as implemented in Pseudo-
monas agents was fitted to the data published in Zaborina et al [26] (see representative
data figures reproduced as Additional Files 5 and 6). The effects of dynorphin on Pseu-
domonas agents demonstrated the activation of the quorum-sensing (QS) control ele-
ment MvfR resulting in peak expression 10 hours after activation (Figure 11). We note
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Figure 10 Cross-model validation of virulence expression in Pseudomonas agents to experiments
of gut epithelial immune activation. This figure displays the results of simulations of GEC agent
production of IFN-g with binding to Pseudomonas agent surface receptor OprF, and subsequent
Pseudomonas agent production of PA-I lectin (see Additional File 4 for experimental referent data).
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Figure 11 Cross-model validation of virulence expression in Pseudomonas agents to experiments
of endogenous opioid production. This figure demonstrates the results of simulations of the production
of endogenous dynorphin by GEC agents in response to a simulation of 20 minutes of ischemia, and the
effects of the dynorphin production on Pseudomonas agents’ levels of MvfR and HQNO production (see
Additional File 5 for sample experimental referent data). Note that there is a discrepancy in the final
trajectory of HQNO production between the ABM and the experimental referent. However, the effect of
this discrepancy is not apparent in the following figures that demonstrate the suppression of commensal
bacterial growth.
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between the ABM seen in Figure 11 and 11the reference data (Additional File 5). How-
ever, as the production of HQNO by activated Pseudomonas agents decreases the
growth rate of commensal microbial flora (i.e. Lactobaccillus species), the discrepancy
in HQNO trajectory is accounted for by the inhibitory effect of HQNO on commensal
flora growth in the presence of dynorphin based on corresponding in vitro studies [26]
and seen in Figure 12 (compare to growth inhibition seen in Additional File 6). Addi-
tionally, given the fact that the GMABM has a fixed nutrient carrying capacity, the
reduction in competition for resources associated with decreased commensal flora
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Figure 12 Cross-model validation of virulence expression in Pseudomonas agents in experiments
of endogenous opioid production manifesting as suppression of commensal bacterial populations.
This figure demonstrates the results of simulations of the production of endogenous dynorphin by GEC
agents in response to a simulation of 20 minutes of ischemia, activation of the virulence factor HQNO in
the Pseudomonas agents and its effect on the suppression of the growth of commensal bacteria (compare
to Additional File 6).
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Figure 13 Cross-model validation to experiments of endogenous opioid production concerning the
population dynamics of Pseudomonas agents and endogenous flora. The competitive advantage of
the Pseudomonas agents is due to the suppression of commensal bacteria resulting from the
Pseudomonas agents’ activation of virulence factors and production of HQNO (which inhibits commensal
bacterial growth) (information extracted from Additional File 6).
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growth (Figure 13).
Overall Model: Integration of modular ABM components to simulate gut-microbe
interactions in a stressed environment
The modular submodel rule sets were integrated into a single “in vivo“ GMABM
intended to be a computational analog to animal models and other more physiologic
experimental platforms. The behavioral algorithms for sense and response virulence
regulation were integrated in Pseudomonas agents maintaining the time-scaled and
semi-quantitative properties of signal transduction pathways from the in vitro ABMs.
The dynorphin and phosphate sensing submodels connected through the pho box-
MvfR interaction; the interferon, dynorphin and adenosine signaling pathways all con-
verge on lecA. Subsequent simulation experiments were performed using the inte-
grated GMABM.
Determination of initial Pseudomonas agent populations
For parameter estimation in the simulated in vivo experiments, an initial Pseudomonas
agent population = 100 was arbitrarily chosen as the start point for the tuning of viru-
lence gene expression. GMABM simulation runs with initial Pseudomonas agents =
100 produced severe defects in barrier function and marked reduction in commensal
flora populations as early as 12 hours after insult, with very high levels of toxin pro-
duction (HQNO), rapid decrease in commensal flora populations and very rapid Pseu-
domonas agent colony growth (Figure 14, uppermost row of screenshots, and
Pseudomonas N0 = 100 on graph). In our assessment, this appeared to be too severe
an effect, not reflective the state space of the clinically relevant situation, and would
not allow investigation of the critical dynamics of the “tipping point” of the system.
Therefore, the initial Pseudomonas agent population was reduced to produce a more
qualitatively realistic progression of injury. This was accomplished with an initial Pseu-
domonas agent number = 10 (Figure 14, second row of screenshots, and Pseudomonas
N0 = 10 on graph). By producing a more realistic injury progression this initial agent
level appeared appropriate for the in vivo GMABM’s level of resolution, allowing
clearer demonstration of the spatial and temporal heterogeneity of the gut environ-
ment. Given this tuning, the GMABM demonstrated expression of PA-I lectin and bac-
terial adhesion appearing at 12 hours post transient ischemic insult, followed by mild
disruption of barrier function at 36 hours and then severe regional defect at 48 hours.
Similarly, simulated Pseudomonas agent population growth emerged at 36 hours with
contiguous colony expansion and barrier disruption at 48 hours (Figure 14, graph).
These results do not have specific in vitro experiments as their reference points; rather,
these dynamics are assessed using the standard of face validity discussed above [68,69]
and used to identify initial simulation conditions sufficient to generate behaviors corre-
lating to those of experimental and clinical interest reflected in the simulation experi-
ments below.
Results
There are three primary goals of the GMABM simulation experiments:
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(b) Examine the sufficiency of existing hypotheses to explain the experimental data.
(c) Potentially guide future experimental design.
In terms of (a); we present a simulated experiment of non-lethal intestinal ischemia/
reperfusion, a circumstance very clinically relevant and seen in conditions associated
Figure 14 Effect of initial Pseudomonas agent population on simulated host injury. Selected frames from
the model interface during simulation of phosphate depletion depict Pseudomonas agents (red pentagons) and
tight junctions (purple background), with black background indicating severe barrier disruption. Upper Row of
Screenshots: An initial Pseudomonas agent population of 100 agents produced rapid and severe barrier
disruption within 12 hours of phosphate depletion and near complete at 36 hours. We considered this to a
disproportionally lethal response and non-realistic calibration behavior. Second Row of Screenshots: An initial
population of 10 Pseudomonas agents produced moderate injury after 48 hours of phosphate depletion. These
dynamics appeared to meet the standard of face validity with respect to the clinically relevant situation, and
provided an enhanced ability to identify the properties of the system’s tipping point. Graph: These graph
demonstrates the relative effect on commensal bacteria and GEC tight junctions at N0 = 100 and 10 respectively.
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inal aortic surgery and initial septic shock of non-gut origin. We use the results of
these simulated experiments to fulfill goal (c) and suggest periods of interesting
dynamics that might affect the timing of sample acquisition in future laboratory experi-
ments. In terms of (b), we examine a divergence between the simulation output of the
GMABM and referent experimental data, and use that insight to effect goal (c) and
posit additional factors that might be investigated to afford reconciliation, some of
which have been pursued.
Simulating non-lethal transient intestinal ischemia
In the traditional laboratory setting, effluent from the lumen of intestinal segments fol-
lowing ischemia reperfusion injury was used in in vitro experiments to study the effects
of endogenous opioids and ischemia byproducts on virulence expression in P. aerugi-
nosa [9,26]. The GMABM was used to simulate 30 minutes of segmental intestinal
ischemia followed by reperfusion injury. Immune activation and phosphate depletion
were initially excluded from the execution of the ischemia/reperfusion simulation. Pre-
sently, there are no published data evaluating Pseudomonas virulence expression and
host survival using an animal model of non-lethal transient intestinal ischemia. How-
ever, the GMABM simulations demonstrated that exposure to select microenvironment
changes in the gut subsequent to transient ischemia/reperfusion injury produced signif-
icant barrier dysfunction (Figure 15), setting the stage for potential host morbidity.
This condition has clinical relevance, as often the onset of critical illness and systemic
inflammation is associated with transient hypotension and hypoperfusion prior to
onset of resuscitative measures [36]. This simulation data also suggests that an in vivo
experiment to confirm this type of behavior should focus its sample collection in the
6-12 hour time frame post -ischemia, and that higher frequency measurements in this
time frame would be substantially more informative as opposed to collections beyond
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Figure 15 GMABM response to transient intestinal ischemia. The effects of 30 minutes of transient
intestinal ischemia, including release of dynorphin and adenosine into the intestinal lumen, were
simulated. We utilized two in silico experimental groups: a control group (Pseudomonas agents = 0) and a
Pseudomonas group (Pseudomonas agents = 10). Transient ischemia alone produced no significant
disruption (Control). The combination of simulated transient intestinal ischemia and the presence of
Pseudomonas agents yielded a 40% decrease in barrier function at 24 hours of simulation time. Note that
the initiation of the effect can be seen between 6 and 12 hours, suggesting that this period should be
targeted for sampling in any future in vivo experiments to obtain the most potentially relevant data.
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Page 25 of 34the 12-hour time point. Work is currently ongoing in terms of the design of the appro-
priate in vivo model in which to evaluate non-lethal transient intestinal ischemia with a
focus on the appropriate phenotypic metrics and high-throughput analysis (metage-
nomics and metatrascriptomics) with which to separate groups.
Reconciliation with in vivo models of gut-derived sepsis
We have developed and published a reproducible model of gut-derived sepsis in mice,
where mice were starved preoperatively, underwent laparotomy with 30% hepatectomy,
followed by cecal injection of P. aeruginosa [5]. Mice exposed to hepatectomy alone or
starvation alone both have very low morbidity and mortality, suggesting that each com-
ponent contributes to a specific and necessary stress signature at the host-microbe
interface. Partial hepatectomy produces systemic physiologic changes related to surgical
stress such as immune activation, catabolic state and phosphate depletion in the intest-
inal mucous layer. The molecular details of the stress signature in the intestinal host-
microbe interface are unclear, but may include immune mediators such as IFN-g,
which is known to induce virulence expression in P. aeruginosa.S t a r v a t i o np r e v e n t s
the repletion of phosphate in the mucous layer in addition to the systemic effects of
nutritional depletion. The requirement of two stress events to produce morbidity and
mortality as a consequence of virulence expression has also been observed in a wet lab
model of C. elegans, where the addition of starvation or heat stress was required to
potentiate the effect of phosphate depletion [24]. The reason for this is unclear, but
likely involves effects on host defenses as well as microbe virulence expression.
T h eG M A B Mw a su s e dt os i m u l a t eh e p a t e c t o my with phosphate repletion (inflam-
mation alone), starvation (phosphate depletion alone) and the combination of the two
(inflammation and phosphate depletion). Simulation of phosphate depletion alone
induced a moderate to severe intestinal barrier dysfunction and reduction of commen-
sal gut flora by 48 hours, with the first indications of patchy breakdown between 24
and 36 hours (Figure 16). Alternatively, simulation of systemic inflammation without
phosphate depletion produced mild, localized patches of barrier defect without pro-
gression from 24 to 48 hours, corroborating the in vivo results suggesting immune
activation alone is insufficient to generate a clinically significant injury (Figure 17).
Simulation of the combined effects of phosphate depletion and inflammation yielded a
more severe injury than phosphate alone, most evident at the 48 hour time point with
Figure 16 GMABM response to phosphate depletion alone. Selected frames from the model interface
taken at 6, 12, 24 and 48 hrs of simulated time during simulation of phosphate depletion in the integrated
GMABM. Pseudomonas agents are red pentagons and intact tight junctions are seen as the purple
background, with black background indicating severe barrier disruption. Phosphate depletion alone yielded
moderate to severe barrier disruption after 48 hours. This response was more severe than expected given
prior experimental referent data.
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Page 26 of 34increased Pseudomonas agent population growth resulting in more severe disruption of
barrier function and greater reduction in commensal flora (Figures 18 and 19).
The results from in vivo studies in the animal model of gut sepsis largely correlate
with the behavior observed in the GMABM, with one exception. In the laboratory,
starvation induces depletion of phosphate in intestinal mucous, but does not alone
lead to morbidity in the animal following cecal injection of P. aeruginosa [23]. The
GMABM predicts a more severe injury than expected in response to only phosphate
depletion (Figure 16). This corresponds to hepatectomy without starvation in the
GMABM, a low mortality condition in the biological experiments. We view this discre-
pancy as representative of exactly the case of a “broken model” that is necessary to
advance knowledge; given the explicit nature of the GMABM its inability in this parti-
cular context to produce output matching the biological referent provides insight into
what additional modifications and investigations need to be pursued in more detail in
the next cycle of experiment and modeling. These future investigations will be elabo-
rated upon in the Discussion.
Discussion
Biology is currently a science in its the discovery phase, where incomplete knowledge,
ambiguity and uncertainty are inevitably present. We suggest that the detailed, selec-
tively qualitative approach to dynamic knowledge representation lies in the fertile
Figure 17 GMABM response to host stress without phosphate depletion. Selected frames from the
model interface taken at 6, 12, 24 and 48 hrs of simulated time during simulation of systemic
inflammation (IFN-ϒ) without phosphate depletion in the integrated GMABM. Pseudomonas agents are red
pentagons and intact tight junctions are seen as the purple background. This set of simulations
demonstrate only mild barrier disruption (grey-black areas), consistent with experimental findings that
immune activation alone in in vivo models is not sufficient to generate a clinically significant injury.
Figure 18 GMABM response to host stress and phosphate depletion. Selected frames from the model
interface taken at 6, 12, 24 and 48 hrs of simulated time during simulation of systemic inflammation (IFN-
ϒ) with phosphate depletion. Pseudomonas agents are red pentagons and intact tight junctions are seen
as the purple background, with black background indicating severe barrier disruption. Phosphate depletion
in conjunction with inflammation combination resulted in the most severe disruption of barrier function.
This finding is consistent with that suggested in prior experimental studies.
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Page 27 of 34middle ground between high resolution, quantitative predictive models and highly
abstracted models of generalize-able functions. This range as previously been well dis-
played in Hunt, et al [34]. It also serves as a reminder that the process of modeling
involves selective abstraction with the goal of gaining insight into the system being
modeled.
Expanding on the role of dynamic knowledge representation, a further advantage of
in silico experimental environments is the ability to implement experimental conditions
not yet developed. This can be useful in the future planning of lines of investigation,
and can potentially predict behaviors when those experimental preparations are even-
tually developed [96]. An example of this capability is demonstrated in the simulations
of non-lethal transient intestinal ischemia, a condition more likely to be clinically rele-
vant than the extreme ischemic insults generally present in wet lab models. As noted
above, while there is currently no published in vivo model of virulence activation in
non-lethal intestinal ischemia/reperfusion injury, the GMABM simulations suggest a
time frame of interest for future sample collections when those laboratory models are
developed. This capability may also be used to refine sampling intervals in existing wet
lab models by uncovering unanticipated dynamic shifts within current sampling
periods.
The behaviors observed in the GMABM during simulated major surgical stress cor-
related with existing animal model findings, with only one exception: the GMABM
demonstrated substantial barrier defect in the context of mucosal phosphate depletion
alone, while in the animal model, phosphate depletion associated with starvation alone
did not produce significant morbidity or mortality, but required a second stress signal
(hepatectomy). As noted above, we view this discrepancy as an opportunity to investi-
gate additional significant factors involved in the in vivo manifestation of P. aeruginosa
virulence effects. We make a series of initial hypotheses concerning the source of dis-
crepancy between the in vivo experiments and the GMABM. These include:
1. Exacerbation of the importance of phosphate sensing on P. aeruginosa virulence
effects. The phosphate sensing pathways are explicitly modeled in the Pseudomonas
agents, but without potential corresponding control pathways that may result in pro-
tective redundancies that provide a damping effect on the low-phosphate sensing trig-
gers of virulence. In order to investigate additional control systems affecting the low
phosphate response, we have already initiated a series of experiments concerning the
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Page 28 of 34complementary importance of iron sensing and metabolism with respect to low-phos-
phate induced virulence (manuscript in preparation). Also, as noted above, there is
also a suggestion of a potential link between the phosphate sensing pathway and
dynorphin response pathway (demonstrated in Figure 7 in terms of a putative link
between pho box and MvfR). Negative feedback or concurrent pathway dependencies
may result in synergistic damping of the virulence response if this link were estab-
lished. We are also in the process of investigating this relationship with additional
experiments.
2. Under-representation of the dynamics of quorum sensing and its influence on P.
aeruginosa population dynamics. The pathways of virulence expression related to phos-
phate depletion are dependent on interactions with the quorum sensing system, a
highly conserved hierarchical circuitry, but as noted in the Methods section, the
GMABM does not incorporate a dynamic switch that links phosphate sensing to
quorum sensing. This relationship has been demonstrated [25], but was not incorpo-
rated into the current ABM given the modeling goal of focusing on the specific viru-
lence pathways. However, given the identified discrepancy between the GMABM and
the experimental findings, we can posit that by setting the quorum-sensing threshold
at the lower point and not accounting for its dynamic shift resulting from low phos-
phate sensing that the GMABM accelerated and exaggerated the virulence due to low
phosphate. This will be rectified in future versions of the GMABM that will incorpo-
rate a more comprehensive representation of the quorum sensing modules and its con-
trols. It is also the case that details of those interactions derived from in vitro studies
may be incomplete, suggesting that the presence of signaling mediators from other
stress signals may be required for complete activation and expression of virulence pro-
ducts. This is further supported by observations in C. elegans models for assessing P.
aeruginosa virulence where heat stress or starvation is required to potentiate the effects
of phosphate depletion [24].
3. Host physiology may be altered in important ways with the addition of a second
stressor that are not represented in the current GMABM. These alterations may
include accentuating the catabolic state and phosphate sequestration, enhancing
immune activation, altering intestinal mucous production and other components of
gut barrier defenses. Given the bacteriocentric emphasis of the current GMABM, these
host systemic factors are highly abstracted, and therefore may (and almost certainly
does) miss key host dynamics that influence P. aeruginosa virulence effects. We note,
however, that this discrepancy would have been present in any standard progression of
experimental models! The benefit of the use of agent-based modeling as dynamic
knowledge representation is that it represents a formal and explicit instantiation of the
particular hypothesis, and therefore can provide more directed guidance as to that
hypothesis’ limitations and means to address them in the next cycle of experiments
and modeling.
Resolving discrepancies between ABM and animal model behaviors may require con-
sideration and representation of both the host and microbe in greater detail. However,
as evidenced in the recent history of translational biomedical research, the range of
possible details to be expanded upon may be too great to be evaluated in an efficient,
or even tractable, manner [70]. In silico dynamic knowledge representation provides an
o p p o r t u n i t yf o rt h er e s e a r c ht oe n g a g ei n“thought experiments” about plausible lines
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Page 29 of 34of investigation, reducing the intellectual and pragmatic overhead in exploring hypoth-
esis-space, thereby enhancing the throughput of hypothesis evaluation. Of course, the
direction of the thought experiments would be informed by the researcher’se x p e r t i s e
and intuition. For instance, in the case of the GMABM:
1. Investigation into mucous barrier physiology and immune activation may provide
justification and guidance for future modifications of the GMABM to test hypotheses
about their role in determining extent of host injury. As noted above, the current
GMABM highly abstracts the host functions concerning the dynamics of maintaining
the mucus layer and, particularly, the immune response. Researchers with a particular
interest and expertise in these areas could speculate as to how their mechanisms of
interest would affect the gut HPI. Dynamic knowledge representation would allow
them to implement much more detailed instantiations of these mechanisms as well as
alternative hypotheses in the GMABM. The behavior of the ABM may then suggest
the type and design of experiments to test and validate these hypotheses, forming part
of an iterative loop of observation, analysis, synthesis and testing.
2. A more detailed representation of the bacterial ecology in the gut, including meta-
bolism, selection, fitness and succession, could result in the incorporation of more
detailed bacterial models into an ABM framework. For instance, there is extensive
work in the area of bacterial metabolism, extending to genome scale models of com-
plete bacterial metabolic networks [97-101]; there may be some point at which this
degree of detailed representation will provide insight into the ecological dynamics asso-
ciated with virulence activation. Currently, the ability to link dynamic models of signal-
ing (essentially mandating a change of state) and flux-balance based models of
metabolism (predicated on steady-state assumptions) is an open area of investigation.
However, the modular architecture of an ABM offers the capability to add and inte-
grate models of such increased detail as the science advances.
The expansibility of ABMs as means of dynamic knowledge representation would
allow the consolidation of multiple streams of mechanistic research into aggregated
ABMs to simulate increasingly complex biological systems. For instance, in the inte-
grated GMABM the behavior of Pseudomonas agents reflects the combined, simulta-
neous effects of all four of the central sense and response pathways for virulence
regulation in response to host stress. We propose that the GMABM of the HPI in an
abstracted model of gut derived sepsis is a starting point to advance the application of
dynamic knowledge representation to the translational efforts regarding the role of the
gut HPI and its relationship in the pathogenesis of nosocomial infections. Furthermore,
we suggest that there is a beneficial role for the use of such relatively abstract and quali-
tative models in the current research environment. In particular, given the inevitable
and unavoidable gaps in knowledge, the use of this type of dynamic knowledge represen-
tation as a “virtual sandbox” where researchers can try out new ideas, construct novel
hypotheses and instantiate ambiguous or competing mechanisms, will be a necessary
capability for dealing with an increasingly data-rich and high-throughput world.
Additional material
Additional file 1: Text File of Netlogo code for the Gut Milieu ABM. The entities, variables and rules are listed
in this file; the components of the user interface are seen at the end of the file. Interested parties may download
the actual model from http://bionetgen.org/SCAI-wiki/index.php/Main_Page.
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Page 30 of 34Additional file 2: Representative data file from original paper concerning the effect of hypoxia and
adenosine demonstrates the production of the PA-I lectin by P. aeruginosa when exposed to media from
control, gut epithelial cells over-expressing HIF, and gut epithelial cells exposed to hypoxia (Figure 2C
from the original publication). Reproduced with permission from [9].
Additional file 3: Representative data file from original paper concerning the effect of low phosphate is a
48 hr Kaplan-Meier survival curve for mice undergoing major surgery (hepatectomy) (Figure 3A from the
original publication), where phosphate is known to be depleted and lethality has been identified to be
due to P. aeruginosa production of PA-I lectin (details in the text). Reprinted with permission from [23].
Additional file 4: Representative data file from original paper on the effect of IFN-g demonstrates the
response of PA-I lectin promoter activity in P. aeruginosa exposed to various pro- and anti-inflammatory
cytokines (Figure 1B from the original publication). Note that the only active curve is that associated with IFN-
g. Reprinted with permission from [8].
Additional file 5: Representative data file from original paper on opioid effects demonstrates the
production of HQNO in response to the synthetic opioid dynorphin (Figure 2C, panel 3 from the original
publication). We note that there is a discrepancy in what appears to be the final trajectory of HQNO production
between the ABM (rising) and this figure (plateau or slightly decreasing). However, this discrepancy does not
appear to influence the effect of HQNO in inhibiting the growth of commensal bacteria (see Additional File 6).
Additional File 5 is reprinted with from [26] under the Creative Commons License.
Additional file 6: Representative data file from original paper on opioid effects demonstrates the role of
HQNO in inhibiting commensal bacterial growth as seen in the difference between the filled triangles and
the other two plots (Figure 7D from the original publication). Additional File 6 is reprinted with from [26]
under the Creative Commons License.
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